Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Tissue Engineered Endothelial Keratoplasty (TE-EK)

NCT04319848 is registered in ClinicalTrials.gov with Singapore Eye Research Institute as lead sponsor.

NCT NCT04319848
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04319848 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Tissue Engineered Endothelial Keratoplasty (TE-EK)
Lead sponsor
Singapore Eye Research Institute
Phase
Phase 1
Overall status
Recruiting
Start date
December 1, 2017
Completion date
June 30, 2028
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bullous keratopathy, fuchs' endothelial dystrophy, mild to moderate corneal endothelial decompensation, post-surgical corneal decompensation (irreversible)